Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (68 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.WT | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > Negative speculation …
View:
Post by jmm1228 on Sep 14, 2023 3:08pm

Negative speculation …

...is almost 100% about liquidity and mostly from posters who have very shallow knowledge of the matter.

There is hardly anything negative posted about the science and the fortress of patent protection that management has put in place.

When this gem finally blossoms these naysayers will find another subject to dump on. It is the way some people are wired and we have our share of those types on this board. So be it.
Comment by N0taP00p on Sep 15, 2023 12:08am
Jmm:  I don't know about you, but I've invested in 4 other Canadian startups besides TLT.  Automotive, med devices, pharmaceutical and rare metals.  Every one of them turned out to be duds.  They sold a lot of tickets to their concerts, which kept getting pushed or cancelled outright.  Maybe I don't know how to pick the diamonds. That's my fault.  For ...more  
Comment by Alamir1111 on Sep 15, 2023 8:10am
I enjoy  reading all posts from members long time investors. What I realized reading other company posters that  here we have some  passion for science really good  research done by posters well written healthy arguments..Hope  you guys will be rewarded for  the efforts you put in .
Comment by jmm1228 on Sep 15, 2023 10:20am
More expeditious financial maneuvering may have accelerated getting to the finish line but at a dilution cost that the powers here decided against. Question is how does ithe pace match up to that dictated by the trial process  and the ability and efficiency of the developers of the science.  There is likely more to the story of the tactics than is understood here.
Comment by N0taP00p on Sep 15, 2023 10:38am
With data that is way better than blockbuster Keytruda, you would think it is relatively easy to get the finances you need. But then again, maybe the side effects of Photofrin have made this a harder obstacle to punch through.  Let's hope TLT can create a whole new paradigm with its new PDT.  This feels like make or break time, given the smaller PP amounts being raised of late. I' ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

View the Presentation

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 68 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250